# Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department

> **NCT01596166** · PHASE4 · COMPLETED · sponsor: **University of Alberta** · enrollment: 56 (actual)

## Conditions studied

- Probable Migraine
- Migraine With Aura
- Migraine Without Aura

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **DRUG:** Metoclopramide

## Key facts

- **NCT ID:** NCT01596166
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2015-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596166, "Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01596166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*